Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 2Phase NA 1Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Mirtazapine × Clear all
NCT04763135 2023-06-08

MIR-P

Hospices Civils de Lyon

Phase 3 Terminated
1 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02336750 2022-04-20

Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis

Fudan University

Phase 3 Completed
212 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡